Mobile-health Network Solutions MNDR
1.36
0.02
1.49%
as of 25 Sep
- Market cap
- $1.7M
- P/E
- —
Follow MNDR
| Jun '25 | Jun '24 | Jun '23 | Jun '22 | |
|---|---|---|---|---|
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
0.00 | 0.00 | 0.00 | 0.00 |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
0.09 | 0.00 | 0.00 | 0.00 |
EV/FCF |
0.08 | 0.00 | 0.00 | 0.00 |
Quick Ratio |
0.77 | 2.19 | 0.96 | 8.22 |
Current Ratio |
1.06 | 2.31 | 1.09 | 8.31 |
Net Debt/EBITDA |
0.31 | 0.43 | 0.70 | (36.48) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
1.23 | 2.45 | 1.11 | 0.00 |
Operating CF/Net income |
1.29 | 0.41 | 0.70 | 10.53 |
Capex/Depreciation |
(14.16) | (0.90) | (1.96) | (0.17) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 |
| (100.17%) | (827.23%) | (79.65%) | 0.00% | |
| (54.58%) | (273.90%) | (45.27%) | 0.00% | |
ROIC |
(139.99%) | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(1,459.79%) | (358.95%) | (810.44%) | 1.00% |
Average Days of Receivables |
12.81 | 5.08 | 8.40 | 10.10 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
60.85% | 129.53% | 54.46% | 23.67% |
Intangible Assets out of Total Assets |
0.53 | 0.00 | 0.02 | 0.01 |
Share Based Compensation of Revenue |
5.42% | 65.29% | 0.00% | 0.00% |
Graham Net Nets |
0.00 | 0.00 | 0.00 | 0.00 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | 0.00% |
Revenue per Share |
51.77 | 97.21 | 15,749.80 | 17,472.00 |
Operating CF per Share |
(29.51) | (44.57) | (4,497.20) | 2,439.25 |
Capex per Share |
(16.49) | (0.93) | (372.00) | (38.00) |
Free Cash Flow per Share |
(46.01) | (45.51) | (4,869.20) | 2,401.25 |
Cash per Share |
7.00 | 46.68 | 4,451.60 | 25,607.75 |
Shareholders Equity per Share |
17.72 | 28.81 | (734.40) | 21,090.25 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
17.72 | 28.81 | (734.40) | 21,090.25 |
Free Cash Flow |
(6.80) | (6.54) | (2.43) | 0.96 |
Working Capital |
0.09 | 4.13 | 0.22 | 9.27 |
Capital Expenditures |
(2.44) | (0.13) | (0.19) | (0.02) |
Net Current Asset Value |
(0.05) | 3.48 | (1.09) | 8.22 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.32 | 0.01 | 0.02 | 0.00 |
Net Profit Margin |
(44.25%) | (111.70%) | (40.81%) | 1.33% |
| Other line items | ||||
Depreciation/Fixed assets |
1.24 | 0.69 | 0.53 | 2.53 |
Cash ROIC |
(123.19%) | (61.04%) | (130.60%) | 5.04% |
Accounts Receivable Turnover |
33.03 | 74.34 | 42.06 | 0.00 |
Accounts Payable Turnover |
5.01 | 7.54 | 7.06 | 0.00 |
Inventory Turnover |
47.53 | 73.65 | 62.17 | 0.00 |
Average Days of Payables |
49.92 | 53.37 | 73.15 | 40.50 |
Days of Inventory on Hand |
5.96 | 5.24 | 7.88 | 5.18 |
Average Receivables |
0.23 | 0.19 | 0.19 | — |
Average Payables |
1.27 | 1.52 | 0.96 | — |
Average Inventory |
0.13 | 0.16 | 0.11 | — |
Average Assets |
6.20 | 5.70 | 7.10 | — |
Average Common Equity |
3.38 | 1.89 | 4.03 | — |
Columns are period end dates